Neurocrine Biosciences
NBIX
#1317
Rank
NZ$30.78 B
Marketcap
NZ$304.16
Share price
0.57%
Change (1 day)
14.42%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): NZ$3.20

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is NZ$12.46. In 2022 the company made an earnings per share (EPS) of NZ$2.88 an increase over its 2021 EPS that were of NZ$1.70.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$3.2011.28%
2022NZ$2.8869.47%
2021NZ$1.70-78.21%
2020NZ$7.80990%
2019NZ$0.7281.82%
2018NZ$0.39-113.5%
2017NZ-$2.910.62%
2016NZ-$2.9057.28%
2015NZ-$1.8425.61%
2014NZ-$1.4718.84%
2013NZ-$1.23-1085.71%
2012NZ$0.13-89.71%
2011NZ$1.22-500%
2010NZ-$0.30-86.92%
2009NZ-$2.32-43.48%
2008NZ-$4.11-57.8%
2007NZ-$9.7492.58%
2006NZ-$5.06371.67%
2005NZ-$1.07-52.76%
2004NZ-$2.2736.56%
2003NZ-$1.66-70%
2002NZ-$5.54118.31%
2001NZ-$2.548.4%
2000NZ-$2.3448.86%
1999NZ-$1.57-20%
1998NZ-$1.97-479.31%
1997NZ$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.27-89.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.46-16.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$55.23 343.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ-$0.36-102.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ-$3.63-129.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$9.26-25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ-$13.50-208.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
NZ$2.73-78.06%๐Ÿ‡ฌ๐Ÿ‡ง UK